ALG1 抗体 (N-Term)
Quick Overview for ALG1 抗体 (N-Term) (ABIN635919)
抗原
See all ALG1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- N-Term
-
特异性
- ALG1 antibody was raised against the N terminal of ALG1
-
纯化方法
- Affinity purified
-
免疫原
- ALG1 antibody was raised using the N terminal of ALG1 corresponding to a region with amino acids VVLGDVGRSPRMQYHALSLAMHGFSVTLLGFCNSKPHDELLQNNRIQIVG
-
-
-
-
应用备注
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
说明
-
ALG1 Blocking Peptide, (ABIN5612017), is also available for use as a blocking control in assays to test for specificity of this ALG1 antibody
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ALG1 antibody in PBS
-
浓度
- Lot specific
-
缓冲液
- PBS
-
注意事项
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
储存条件
- 4 °C/-20 °C
-
储存方法
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- ALG1 (Chitobiosyldiphosphodolichol beta-Mannosyltransferase (ALG1))
-
别名
- ALG1
-
背景
- ALG1 catalyzes the first mannosylation step in the biosynthesis of lipid-linked oligosaccharides. Defects in ALG1 are the cause of congenital disorder of glycosylation type 1K (CDG1K).
-
分子量
- 52 kDa (MW of target protein)
抗原
-